RNA Splicing Defects in Hypertrophic Cardiomyopathy: Implications for Diagnosis and Therapy
February 16, 2020
A new paper from the group of our EU-CardioRNA member Maria Carmo-Fonseca on the emerging role of RNA mis-splicing in hypertrophic cardiomyopathy. Published in our IJMS Special Issue “RNAs in Cardiovascular Diseases-CardioRNA EU COST Action”
Access the article